58 related articles for article (PubMed ID: 17201154)
1. Reduced heterochromatin protein 1-beta (HP1beta) expression is correlated with increased invasive activity in human melanoma cells.
Nishimura K; Hirokawa YS; Mizutani H; Shiraishi T
Anticancer Res; 2006; 26(6B):4349-56. PubMed ID: 17201154
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation.
Wellbrock C; Marais R
J Cell Biol; 2005 Aug; 170(5):703-8. PubMed ID: 16129781
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
[TBL] [Abstract][Full Text] [Related]
4. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
[TBL] [Abstract][Full Text] [Related]
5. Analysis of HP1α regulation in human breast cancer cells.
Thomsen R; Christensen DB; Rosborg S; Linnet TE; Blechingberg J; Nielsen AL
Mol Carcinog; 2011 Aug; 50(8):601-13. PubMed ID: 21374739
[TBL] [Abstract][Full Text] [Related]
6. Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas.
Dynek JN; Chan SM; Liu J; Zha J; Fairbrother WJ; Vucic D
Cancer Res; 2008 May; 68(9):3124-32. PubMed ID: 18451137
[TBL] [Abstract][Full Text] [Related]
7. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression.
Kim A; Yang Y; Lee MS; Yoo YD; Lee HG; Lim JS
Pigment Cell Melanoma Res; 2008 Dec; 21(6):653-64. PubMed ID: 19067970
[TBL] [Abstract][Full Text] [Related]
8. Induction of microphthalmia transcription factor (Mitf) by forskolin and stimulation of melanin release in UISO-Mel-6 cells.
Lekmine F; Salti GI
J Surg Res; 2008 Sep; 149(1):27-30. PubMed ID: 18028952
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines.
Bemis LT; Chen R; Amato CM; Classen EH; Robinson SE; Coffey DG; Erickson PF; Shellman YG; Robinson WA
Cancer Res; 2008 Mar; 68(5):1362-8. PubMed ID: 18316599
[TBL] [Abstract][Full Text] [Related]
10. Identification of distinct changes in gene expression after modulation of melanoma tumor antigen p97 (melanotransferrin) in multiple models in vitro and in vivo.
Suryo Rahmanto Y; Dunn LL; Richardson DR
Carcinogenesis; 2007 Oct; 28(10):2172-83. PubMed ID: 17449903
[TBL] [Abstract][Full Text] [Related]
11. Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells.
Goodall J; Carreira S; Denat L; Kobi D; Davidson I; Nuciforo P; Sturm RA; Larue L; Goding CR
Cancer Res; 2008 Oct; 68(19):7788-94. PubMed ID: 18829533
[TBL] [Abstract][Full Text] [Related]
12. Constitutive heterochromatin during mouse oogenesis: the pattern of histone H3 modifications and localization of HP1alpha and HP1beta proteins.
Meglicki M; Zientarski M; Borsuk E
Mol Reprod Dev; 2008 Feb; 75(2):414-28. PubMed ID: 17891782
[TBL] [Abstract][Full Text] [Related]
13. RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas.
Fagiani E; Giardina G; Luzi L; Cesaroni M; Quarto M; Capra M; Germano G; Bono M; Capillo M; Pelicci P; Lanfrancone L
Cancer Res; 2007 Apr; 67(7):3064-73. PubMed ID: 17409413
[TBL] [Abstract][Full Text] [Related]
14. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF
Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
[TBL] [Abstract][Full Text] [Related]
15. Expression of E1AF, an ets-oncogene transcription factor, highly correlates with malignant phenotype of malignant melanoma through up-regulation of the membrane-type-1 matrix metalloproteinase gene.
Hata H; Kitamura T; Higashino F; Hida K; Yoshida K; Ohiro Y; Totsuka Y; Kitagawa Y; Shindoh M
Oncol Rep; 2008 May; 19(5):1093-8. PubMed ID: 18425363
[TBL] [Abstract][Full Text] [Related]
16. In vivo switching of human melanoma cells between proliferative and invasive states.
Hoek KS; Eichhoff OM; Schlegel NC; Döbbeling U; Kobert N; Schaerer L; Hemmi S; Dummer R
Cancer Res; 2008 Feb; 68(3):650-6. PubMed ID: 18245463
[TBL] [Abstract][Full Text] [Related]
17. c-Met is a potentially new therapeutic target for treatment of human melanoma.
Puri N; Ahmed S; Janamanchi V; Tretiakova M; Zumba O; Krausz T; Jagadeeswaran R; Salgia R
Clin Cancer Res; 2007 Apr; 13(7):2246-53. PubMed ID: 17404109
[TBL] [Abstract][Full Text] [Related]
18. Expression patterns of S100 proteins in melanocytes and melanocytic lesions.
Petersson S; Shubbar E; Enerbäck L; Enerbäck C
Melanoma Res; 2009 Aug; 19(4):215-25. PubMed ID: 19521263
[TBL] [Abstract][Full Text] [Related]
19. Microphthalmia-associated transcription factor gene amplification in metastatic melanoma is a prognostic marker for patient survival, but not a predictive marker for chemosensitivity and chemotherapy response.
Ugurel S; Houben R; Schrama D; Voigt H; Zapatka M; Schadendorf D; Bröcker EB; Becker JC
Clin Cancer Res; 2007 Nov; 13(21):6344-50. PubMed ID: 17975146
[TBL] [Abstract][Full Text] [Related]
20. Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma.
Sato K; Toriyama M
J Dermatol Sci; 2009 Feb; 53(2):140-5. PubMed ID: 19013771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
